Question: normalizaton between studies
0
gravatar for Arne.Muller@aventis.com
14.9 years ago by
Arne.Muller@aventis.com620 wrote:
Dear All, I'd like to continue on the topic I've posted a few daysa go ("unbalanced design") - but in a slightly different direction ... I'm trying to figure out a dose response from an experiment (affy) that was conducted in three independent studies (basically each study conducted the same dose treatment, using slightly different protocols). I'd like to find genes that are consitently modulated by dose across the three studies using a linear model: value ~ study + dose + study:dose The problem is that the studies have quite different intensity distributions of the PMs). I've some doubts that RMA or VSN are appropiate normalization methods for this problem. Forcing all distributions to be the same may buffer the very strong study effect but may also erase some of the tiny (but significant) differences due to dose. I think the linear model above should take care of study differences, so maybe a less stringent normalization would do it. I'd be interested what normalization people use for this type of analysis. kind regards, Arne
normalization vsn dose • 541 views
ADD COMMENTlink modified 14.9 years ago by Anja.von.Heydebreck@merck.de10 • written 14.9 years ago by Arne.Muller@aventis.com620
Answer: normalizaton between studies
0
gravatar for Anja.von.Heydebreck@merck.de
14.9 years ago by
Dear Arne, > The problem is that the studies have quite different intensity > distributions of the PMs). I've some doubts that RMA or VSN are > appropiate normalization methods for this problem. Forcing all > distributions to be the same may buffer the very strong study > effect but may also erase some of the tiny (but significant) > differences due to dose. Actually, VSN does not enforce intensity distributions to be the same. The normalization in VSN amounts to an affine-linear mapping of the intensities of each chip, that is, for each chip only a multiplicative/scaling factor and an additive offset are estimated from the data. Best regards, Anja -- Dr. Anja von Heydebreck Global Technologies Bio- and Chemoinformatics Merck KGaA 64271 Darmstadt Germany Phone: +49-6151-723235, Fax: +49-6151-723329 Email: anja.von.heydebreck@merck.de http://www.merck.de
ADD COMMENTlink written 14.9 years ago by Anja.von.Heydebreck@merck.de10
Please log in to add an answer.

Help
Access

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.
Powered by Biostar version 16.09
Traffic: 209 users visited in the last hour